Laboratorio Farmaceutico Erfo Logo

Laboratorio Farmaceutico Erfo

ERFO | XMIL

Overview

Corporate Details

ISIN(s):
IT0005497836 (+1 more)
LEI:
8945005CB564D0OBQQ85
Country:
Italy
Address:
VIALE GEKI RUSSO, SNC (PONTE GALLO), 98049 VILLAFRANCA TIRRENA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorio Farmaceutico Erfo S.p.A. is an innovative SME and Benefit Corporation operating in the nutraceutical sector. The company specializes in contract manufacturing, offering comprehensive services for the formulation, production, and packaging of food supplements and natural medicines for third-party brands. Its modern, ISO 9001:2015 certified facility produces a variety of pharmaceutical forms, including capsules, tablets, sachets, vials, and bottles. Erfo provides a full-service 'all-in-one' solution that encompasses R&D, legal consulting, copywriting, and packaging design. The company prioritizes high-quality raw materials, sourcing extracts from global phytotherapeutic traditions, and supports clients with flexible production, including small batches.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Laboratorio Farmaceutico Erfo. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-28 18:09
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A.: 1H 2025 financial figures
English 502.5 KB
2025-08-28 13:00
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A. - Comunicazione dati gestionali IH 2025
Italian 334.1 KB
2025-08-20 23:05
Director's Dealing
Comunicazione internal dealing
Italian 87.4 KB
2025-08-09 11:14
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 377.2 KB
2025-08-02 09:19
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.9 KB
2025-07-25 20:05
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 374.5 KB
2025-07-18 20:04
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 377.1 KB
2025-07-12 09:39
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.4 KB
2025-07-04 18:21
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.3 KB
2025-07-02 20:45
Director's Dealing
Comunicazione internal dealing
Italian 87.4 KB
2025-06-28 14:02
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.9 KB
2025-06-21 09:57
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.7 KB
2025-06-21 09:36
Share Issue/Capital Change
Laboratorio Farmaceutico Erfo S.p.A. - Chiusura del terzo periodo di esercizio …
Italian 429.5 KB
2025-06-14 16:38
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.4 KB
2025-06-06 23:00
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.0 KB

Automate Your Workflow. Get a real-time feed of all Laboratorio Farmaceutico Erfo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Laboratorio Farmaceutico Erfo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK